BILLERICA, Mass. --(BUSINESS WIRE)--May 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the three months ended March 31, 2023 . “Our corporate transformation initiated in August

BILLERICA, Mass. --(BUSINESS WIRE)--May 2, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, May 9, 2023 , to discuss its first quarter 2023 financial results.

Blood-based measurement of neurofilament light chain (NfL) provides compelling evidence to support an accelerated drug approval by the FDA. The decision has positive implications for NfL blood testing as a key tool in neuro-drug development. BILLERICA, Mass. --(BUSINESS WIRE)--Apr.

BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 8, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Barclays Global Healthcare Conference on Wednesday,

BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 6, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended December 31, 2022 .

BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 28, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s 43rd Annual Health Care Conference .

BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 24, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Monday, March 6, 2023 , to discuss its fourth quarter earnings and full year

BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023 . Mr.

New CLIA blood test expands access to important “brain health” biomarker to advance research and clinical care BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 9, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive

BILLERICA, Mass. --(BUSINESS WIRE)--Jan. 3, 2023-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the 41 st Annual J.P.